NGS Solutions
NGS’ Healthy Heights Available at Walmart
Walmart now stocking Healthy Heights with significant opportunities for expansion
Mor Research Applications
IIA invests 25M NIS in innovation center in Be’er Sheva
Synergy 7 jointly owned by Mor, Ben Gurion U, B.G. Negev, Soroka , Elbit , Incubit Technological Entrepreneurship and Merage
Exero Medical
Exero’s Pivotal Clinical Study Approved by WCG
Exero’s multi-center study expected to commence during Q1 2024.
Can-Fite
CAN-FITE expands license deal with Ewopharma
Exclusive distribution agreement for psoriasis and hepatocellular carcinoma (HCC) and nonalcoholic steatohepatitis (NASH).
Mediwound
Mediwound announces positive data from clinical study
Phase I/II study evaluated safety and efficacy of MW005 for low-risk Basal Cell Carcinoma (BCC).
Cathworks
Cathworks announces first patient in clinical trial
Evaluates the clinical benefits of FFRangio® System in coronary artery disease (CAD)
Nanox
Nanox.AI New Global Partnership with Ferrum Health
Partnership on AI platform – Bone solution (HealthOST) and cardiac solution (HealthCCSng)
Exero
Unorthodox Ventures Invests in Exero Medical
Unorthodox and Founder Carey Smith provide bridge financing toward a series A round
DiA
DiA Secures FDA Clearance for its New AI Software
LVivo IQS for cardiac ultrasound users with real-time image quality feedback while scanning
Purple Biotech Inks Deal With Mor
The agreement provides Purple first access to early-stage oncology product candidates owned by Mor
